Spyre Therapeutics Inc (SYRE)

Operating Expenses

$201.34M

TTM · Period ending: · USD

SYRE logo

SYRE Operating Expenses

Latest reported$201.34M
SYRE Operating Expenses ($8.89M → $201.34M)
High-resolution chart · PNG

SYRE operating expenses history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Spyre Therapeutics Inc Operating Expenses — Annual fiscal periods (USD)
Period endingOperating Expenses (USD)
37,909,000
208,566,000
243,189,000
87,110,000
84,388,000
79,857,000
79,433,000
49,351,000
32,881,000
26,534,000
17,400,000
8,885,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.